TRIMEDYNE INC - FORM 10-K - XML - IDEA: XBRL DOCUMENT - January 29, 2013

Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR50.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR43.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR20.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR38.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR27.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR10.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR5.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR41.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR49.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR26.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR21.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR51.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR34.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR16.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR13.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR15.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR19.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR23.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR11.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR12.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR4.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR18.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR1.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR17.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR3.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR7.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR24.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR36.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR22.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR35.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR6.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR45.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR2.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR53.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR40.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR32.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR8.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR31.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR30.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR44.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR28.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR29.htm
EXCEL - IDEA: XBRL DOCUMENT - TRIMEDYNE INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR9.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR47.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR52.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR37.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR42.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR25.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR33.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR46.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR55.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR48.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR54.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR39.htm
EX-32.2 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3202.htm
EX-32.1 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3201.htm
EX-31.2 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3102.htm
EX-31.1 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3101.htm
10-K - FORM 10-K - TRIMEDYNE INCtmed_10k-093012.htm
v2.4.0.6
8. Stockholders' Equity
 12 Months Ended
Sep. 30, 2012
Equity [Abstract]  
NOte 8 - Stockholders' Equity

Warrants

 

The following is a summary of warrants outstanding during the years ended September 30, 2012 and 2011:

 

    Shares of Common Stock Issuable Upon
Exercise of Warrants		     Weighted Average Exercise Price
Per Share		     Range of
Exercise
Prices		  
Outstanding, at October 1, 2010     212,000     $ 1.25     $ 1.25  
                         
Issued     –                  
Outstanding, at September 30, 2011     212,000     $ 1.25     $ 1.25  
                         
Expired     (212,000 )                
Outstanding, at September 30, 2012     –     $ –     $ –  

  

Stock Options

 

The Company has adopted stock option plans that authorize the granting of options to key employees, directors, and consultants to purchase unissued common stock subject to certain conditions, such as continued employment. Options are generally granted at the fair market value of the Company's common stock at the date of grant, become exercisable over a period of five years from the date of grant, and generally expire in six or ten years specific to their respective plan. Forfeitures of stock options are returned to the Company and become available for grant under the respective plan. Upon exercise the Company issues new shares of common stock.

 

During the fiscal year ended September 30, 2012, the Board of Directors authorized the grant of 281,000 non-qualified options. On October 10, 2011, the Board of Directors approved the exchange of 171,000 out-of-money, fully-vested stock options, to certain employees, for an equal number of stock options at the current market price on that date of $0.13 per option. As a result of the modification, the Company recorded an additional expense of $9,000. On May 17, 2012, the Board of Directors authorized the grant of fully vested, non-qualified stock options to purchase 110,000 shares to two individuals, with an exercise, price per share of $0.05, based on the closing price of the Company's common stock on the date of grant

 

On May 10, 2011, the Board of Directors authorized the grant of non-qualified stock options to purchase 469,000 shares to 19 individuals. The exercise price per share was $0.14, based on the closing price of the Company's common stock on the date of grant. The majority of these options vest over three years and expire ten years from the date of grant.

 

Stock Options Outstanding:

 

                Weighted-        
                Average        
          Weighted-     Remaining        
          Average     Contractual     Aggregate  
          Exercise     Term     Intrinsic  
    Shares     Price     (Years)     Value  
Options outstanding at
October 1, 2010		     1,051,579     $ 0.84                  
                                 
Options granted     469,000       0.14                  
Options exercised     –       –                  
Options forfeited     (382,200 )     0.95                  
                                 
Options outstanding at September 30, 2011     1,138,379     $ 0.51                  
                                 
Options granted     281,000       0.10                  
Options exercised     –       –                  
Options forfeited     (415,729 )     0.92                  
                                 
Options outstanding at September 30, 2012     1,003,650     $ 0.23       5.4     $ –  
                                 
Options exercisable at September 30, 2012     778,850     $ 0.25       5.1     $ –  

   

On August 13, 2003 the Company's Board of Directors adopted the 2003 Non-statutory Stock Option Plan ("2003 Plan") for issuance of stock options to employees and others. Under the 2003 Plan, the Company reserved two million shares for issuance. As of September 30, 2012 and 2011, 996,350 and 1,109,960 options were available for issuance under the 2003 Plan, respectively.

 

The following table summarizes information concerning outstanding and exercisable options at September 30, 2012:

 

    OPTIONS OUTSTANDING     OPTIONS EXERCISABLE  
Range of
Exercise Prices		   Outstanding as of
9/30/2012		     Weighted-Average Remaining
Contractual Life (years)		     Weighted-Average
Exercise Price		     Exercisable as of 9/30/2012     Weighted-Average
Exercise Price		  
$     0.13 - 0.32       792,000       6.3     $ 0.14       567,200     $ 0.13  
$     0.33 - 0.55       87,500       0.9     $ 0.51       87,500     $ 0.51  
$     0.56 – 0.68       124,150       2.8     $ 0.61       124,150     $ 0.61  
              1,003,650       5.4     $ 0.23       778,850     $ 0.25  

 

The weighted-average grant date fair value of options granted during the fiscal years ended September 30, 2012 and 2011, was $0.10 and $0.14 per option, respectively. There were no options exercised during the fiscal years ended September 30, 2012 and 2011.

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by TRIMEDYNE INC and has no official or unofficial affiliation with TRIMEDYNE INC


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.